GLP-1 Leads to Similar Cognitive Outcomes as Other Diabetes Drugs, Trial Data Show

By News Health
6 hours Ago

(MedPage Today) — Cognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the GRADE clinical trial showed.
Cognitive performance at 4.1 years of follow-up was similar in participants…

Source link : https://www.medpagetoday.com/neurology/dementia/115661

Author :

Publish date : 2025-05-19 21:31:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

My AI therapist got me through dark times

AI doesn't know 'no' – and that's a huge problem for medical bots

Routine Antibiotics Appear to Hold No Benefit in Non-Severe COVID-19

Best Intensive Care Unit Sedative? Head-to-Head Trial Weighs In

New Dads, Non-Birthing Partners Less Likely to Get Prenatal Counseling on Vaccines

Novel Drug Reduced Bulging in Active and Chronic Thyroid Eye Disease